1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
HOME > ORGANIZATION
ORGANIZATION
- FPMAJ Subcommittee Says NHI Prices of Essential Drugs Should Be Maintained; Stable Supply System for Disasters Envisioned as Requirement
June 11, 2013
- 30% of Newly Listed Drugs in FY2012 Developed at Request of Govt: FPMAJ Survey
June 10, 2013
- FPMAJ Committee Appoints Eisai’s Tsuchiya, Takeda’s Aoyagi as Vice Chairman
June 7, 2013
- Consumers Need to Take Caution with Online OTC Drug Sales: Keizai Doyukai Chairman Hasegawa
June 7, 2013
- Lifting of Ban on Online OTC Drug Sales Would “Create Situation of Grave Concern”: JMA Vice President Nakagawa
June 7, 2013
- Pros and Cons of Bungyo Should Be Reconsidered: JMARI Working Paper
June 6, 2013
- Sawai Gains Steady Market Shares of Generics in Broad Categories, Meiji Seika Pharma Strong in CNS: Survey
June 4, 2013
- ACCJ, EBC Advocate Preventive Health, Say Physicians Should Earn More by Keeping People Out of Hospitals
June 3, 2013
- Fewer Drug Makers Used Outside Organizations for MR Education and Training in FY2012: MREAC
June 3, 2013
- Drug Makers, R&D Organizations Sign Memorandum to Search Compounds for Infectious Disease Treatment: GHIT Fund
June 3, 2013
- JMA Demands Novartis Disclose Details of Internal Probe
May 31, 2013
- Actions Taken in 29 Prefectures to Eliminate Free Benefits and Labor Provided by Wholesalers: Industry FTC Reports
May 29, 2013
- Towa’s Yoshida Appointed New JGA President, Says Achieving Roadmap Goals Important
May 23, 2013
- EFPIA Japan Chairman Fauchet Prods for Review of 14 Day Prescription Limit
May 21, 2013
- New PhRMA Chairman Tells Prime Minister Abe, Pro-Innovation Policies Key to Maintaining Japanese Healthcare System
May 16, 2013
- Kyokai Kenpo Launches Trial Notification Service on Copayment Differences between Original, Generic Anti-Allergy Drugs
May 8, 2013
- Vital-Net Pres. Suzuki Tipped to Be Next President of JPWA; Number of VPs to Be Increased to 5
May 2, 2013
- Itsuro Yoshida of Towa Pharmaceutical Expected to Take Over as Next President of JGA
April 25, 2013
- “Both Sides Need to Work Harder” to Reach Agreements on Delivery Prices: Mr Nakamura of NPhA
April 23, 2013
- JPMA to Call on Its Member Companies to Ask Lecturers at Seminars Sponsored by Them for Their Permission to Disclose COI-Related Information
April 22, 2013
ページ
In late January, a bill to amend the Pharmaceuticals and Medical Devices Act cleared key legislation review processes by the…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…